On Tuesday, Following Stocks were among the “Top Losers” of U.S. Stock Market: Corning Inc. (NYSE:GLW), Sinclair Broadcast Group, Inc. (NASDAQ:SBGI), American Tower Corporation (NYSE:AMT), Celgene Corporation (NASDAQ:CELG)
Corning Inc. (NYSE:GLW), with shares declined -2.41%, closed at $22.68.
Sinclair Broadcast Group, Inc. (NASDAQ:SBGI), with shares dropped -2.91%, settled at $31.41.
American Tower Corporation (NYSE:AMT), with shares dipped -2.09%, and closed at $94.15.
Celgene Corporation (NASDAQ:CELG), plummeted -3.95%, and closed at $115.28.
Latest NEWS regarding these Stocks are depicted underneath:
Corning Inc. (NYSE:GLW)
Corning Inc. (GLW), declared that it has accomplished the formerly declared attainment of Samsung Electronics Co., Ltd.`s fiber optics business.
Samsung Electronics is a trusted provider of optical fiber, cable, and connectivity for customers in South Korea, China, and Southeast Asia. Corning will integrate Samsung Electronics` fiber optics business, with manufacturing facilities in Gumi, South Korea, and in Hainan, China, into the Corning Optical Communications business segment. The attainment augments Corning`s market access and enhances its broad portfolio of optical communications products in Asia.
Corning (www.corning.com) is one of the world`s leading innovators in materials science. For more than 160 years, Corning has applied its unparalleled expertise in specialty glass, ceramics, and optical physics to develop products that have created new industries and transformed people`s lives.
Sinclair Broadcast Group, Inc. (NASDAQ:SBGI)
Sinclair Broadcast Group, Inc. (SBGI), declared that it has launched Sinclair Digital Ventures, a division of the Corporation that will invest in emerging digital technologies and digital content companies. SDV will focus on companies with products or services that support and expand Sinclair’s digital capabilities and non-linear footprint. The division will be overseen by David Amy, Sinclair’s COO, Chris Ripley, Sinclair’s CFO, and Rob Weisbord, Chief Operating Officer, Sinclair Digital Group.
“Expansion of our digital footprint is integral to our longer term growth plan, especially as viewing consumption trends evolve,” commented David Smith, President and CEO, Sinclair. “Sinclair Digital Ventures’ focus is to seek partner companies whose products or services can assist engage consumers and advertisers on multiple screens - web, social media and mobile apps. We presently have several potential investments in the Digital Ventures pipeline whose emphases are on advancing advertiser reach, enhancing the users’ digital experience, and/or improving our digital content. With this declaration, we look forward to initiating conversations with other such partners.”
Sinclair Broadcast Group, Inc., a diversified television broadcasting corporation, owns and operates, programs, or provides sales services to television stations in the United States.
American Tower Corporation (NYSE:AMT)
American Tower Corporation (AMT), declared its election to call for redemption all of its outstanding 7.000% senior unsecured notes due 2017. The redemption date has been set for April 29, 2015. In accordance with the redemption provisions of the notes and the indenture dated as of October 1, 2007, the notes will be redeemed at a price equal to the principal amount of the notes plus a make-whole premium calculated following the terms of the indenture, together with accrued and unpaid interest, if any, up to, but not including, the redemption date. The Corporation intends to fund the redemption with borrowings under its credit facilities and cash on hand.
American Tower is a leading independent owner, operator and developer of communications real estate with a global portfolio of over 87,000 communications sites.
Celgene Corporation (NASDAQ:CELG)
Celgene Corporation (CELG), will visit the Nasdaq MarketSite in Times Square.
In honor of the occasion, Robert Hugin, Chairman & CEO will ring the Closing Bell.
Where: Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio
When: Wednesday, April 1, 2015 – 3:45 p.m. to 4:00 p.m. ET.
Celgene Corporation, a biopharmaceutical corporation, discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases in the United States and Internationally.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
